FemasysFEMY -4.16%55 Buyback Yield % is -115.03 as of Jul. 05, 2026. GuruFocus rates FEMY with a GF Score™ of 55/100 and a GF Value™ of $12.17 (Possible Value Trap). The stock has 7 warning signs investors should review. Among 347 Medical Devices & Instruments companies, Femasys ranks worse than 94.81% on this metric.
Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.
The historical data trend for Femasys's Buyback Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FEMY vs UEEC, BNGO, CUPR: Buyback Yield % Comparison
For the Medical Instruments & Supplies subindustry, Femasys's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Femasys Buyback Yield % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Femasys's Buyback Yield % distribution charts can be found below:
* The bar in red indicates where Femasys's Buyback Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Femasys (FEMY) has a Buyback Yield % of -115.03 as of Jul. 05, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Femasys and its competitors. According to the industry distribution chart, Femasys ranks #329 out of 347 companies in the Medical Devices & Instruments industry, placing it in the top 94.8%.
Is Femasys' Buyback Yield % too high?
Femasys' current Buyback Yield % is -115.03. Based on the distribution chart, Femasys ranks #329 out of 347 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Femasys has a GF Score™ of 55/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Femasys' Buyback Yield % compare to UEEC and BNGO?
According to the Medical Devices & Instruments industry distribution chart, Femasys ranks #329 out of 347 companies for Buyback Yield %. This places Femasys in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Medical Devices & Instruments company?
A good Buyback Yield % depends on the Medical Devices & Instruments industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Femasys and its competitors. Femasys's current Buyback Yield % is -115.03. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Femasys stock overvalued right now?
Based on GuruFocus' analysis, Femasys (FEMY) is currently considered Possible Value Trap. The stock's GF Value™ is $12.17, compared to a current price of $4.17 — trading 65.7% below its estimated fair value. The current Buyback Yield % is -115.03. Femasys' overall GF Score™ is 55/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For Femasys (FEMY), the current Buyback Yield % is -115.03 as of Jul. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Femasys (FEMY) Overvalued in 2026?
Based on GuruFocus' analysis, Femasys stock appears to be undervalued.
The current stock price of $4.17 is trading 65.7% below its estimated GF Value™ of $12.17.
GuruFocus considers Femasys to be Possible Value Trap.
Key valuation signals for FEMY:
Buyback Yield %: -115.03
GF Value™: $12.17 vs. price of $4.17 (65.7% below fair value)
No single metric tells the full story. See the FEMY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Femasys Inc is a biomedical company focused on transforming women's healthcare by developing solutions and advancements providing clinical impact to address severely underserved areas. The company's mission is to provide women with minimally invasive, non-surgical product technologies, accessible in the office, improving patient care and overall health economics. Its product portfolio includes FemaSeed Intratubal Insemination, an infertility treatment; FemVue, a companion diagnostic for fallopian tube assessment via ultrasound; FemBloc, a clinical product candidate being developed as a permanent birth control; FemCerv, a tissue sampler for cervical cancer diagnosis; and FemCath and FemChec. Geographically, it derives key revenue from the United States and rest from international markets.
55GF Score
Get the complete analysis for FEMY
Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FEMY has been successfully added to your 
